NCT00836953View on ClinicalTrials.gov

Study to Collect Sera for Immunogenicity Testing in Children Vaccinated With Fluzone®

PHASE4CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

January 31, 2004

Study Completion Date

July 31, 2004

Conditions
Influenza
Interventions
BIOLOGICAL

Influenza virus vaccine (Pediatric formulation)

0.25 mL, Intramuscular

Trial Locations (1)

23510

Norfolk

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT00836953 - Study to Collect Sera for Immunogenicity Testing in Children Vaccinated With Fluzone® | Biotech Hunter | Biotech Hunter